Shelley Bunting
Acute Care · Aurora, CONPI 1437371457
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.0%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 68.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $4,733 and has fallen 96.0% since, to $191 in 2025. Among acute care clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $50.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Sanofi$649
- Regeneron Healthcare Solutions, Inc.$461
- LEO Pharma Inc.$400
- Novartis$307
- Sun Pharmaceutical Industries Inc.$218
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$5,80054%
- Travel & lodging$1351%
- Food & beverage$4,66143%
- Education$1381%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $7,310 |
| Sanofi | 15 | $649 |
| Regeneron Healthcare Solutions, Inc. | 15 | $461 |
| LEO Pharma Inc. | 19 | $400 |
| Novartis | 20 | $307 |
| Sun Pharmaceutical Industries Inc. | 11 | $218 |
| Pfizer | 11 | $211 |
| Lilly USA, LLC | 12 | $205 |
| Johnson & Johnson | 5 | $190 |
| Incyte Corporation | 6 | $188 |
| Amgen | 4 | $113 |
| UCB, Inc. | 3 | $96 |
| Almirall LLC | 3 | $77 |
| E.r. Squibb & Sons, L.L.C. | 4 | $77 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Galderma Laboratories, L.p. | 3 | $49 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $40 |
| Journey Medical Corporation | 2 | $35 |
| EPI Health, LLC | 2 | $27 |
| Biofrontera Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,734 in reported general payments places this provider in the 95th percentile of 239 acute care providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 76 | $1,726 |
| Clobetasol Propionate | 30 | $1,534 |
| Ketoconazole | 44 | $928 |
| Mupirocin | 41 | $643 |
| Hydrocortisone | 36 | $506 |
| Levocetirizine Dihydrochloride | 22 | $444 |
| Prednisone | 15 | $103 |
Paid to pharmacies, not to this prescriber.
Other acute care in Aurora
- Rachele RobertsAurora$19K
- Chishamiso MagayisaAurora$4K
- Fe Estelita BernardoAurora$2K
- Kathryn RaffertyAurora$1K
- Emily TempletonAurora$1K
- Mary MauckAurora$987
- Tiffany MorganColorado Springs$590K
- Wendy StevensCortez$57K
- Peter ByrneLone Tree$56K
- Paige YountColorado Springs$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.